EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
AIM ImmunoTech Inc. (AIM) had EBITDA Margin of -15675.25% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.20M |
|
$-28.96M |
|
$0.04M |
|
$0.16M |
|
$32.12M |
|
$-31.92M |
|
$2.95M |
|
$-28.96M |
|
$-29.18M |
|
$-28.96M |
|
$-28.96M |
|
$-28.96M |
|
$-29.18M |
|
$-31.92M |
|
$-31.66M |
|
48.59M |
|
48.59M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$14.56M |
|
$0.13M |
|
$4.83M |
|
$19.38M |
|
$8.65M |
|
-- |
|
$0.49M |
|
$9.15M |
|
$9.54M |
|
$7.92M |
|
$10.23M |
|
49.10M |
|
| Cash Flow Statement Financials | |
$-21.27M |
|
$-0.83M |
|
$0.48M |
|
$27.05M |
|
$5.44M |
|
$-21.61M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
79.21% |
|
-15800.00% |
|
-15800.00% |
|
|
EBITDA Margin |
-15675.25% |
-14337.62% |
|
-14337.62% |
|
$-21.22M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.17 |
|
2139.41 |
|
-303.43% |
|
-365.64% |
|
-149.44% |
|
-283.00% |
|
$0.21 |
|
$-0.44 |
|
$-0.44 |
|